Case 1:07—cv—00255-JJF Document 175 Filed 06/27/2008 Page 1 of 1
Frederick L. Cottrell, un F
302-651-7509
Parkins@r|f.com
June 27, 2008
BY HAND DELIVERY AND
ELECTRONIC FILING
The Honorable Joseph J . Farnan, Jr.
United States District Court
844 King Street
Wilmington, DE 19801
Re: Purdue Pharma Products LP., et al. v. Par Pharmaceutical, Inc.,
C.A. No. 07-255-JJF
Dear Judge Farnan:
This is in response to Mr. Green’s letter tiled earlier today regarding canceling the
July ll, 2008 oral argument on Grunenthal USA’s Motion to Quash Par’s subpoena in Civil
Action No. 07-255 (Purdue v. Par). Given Par’s outstanding motion for issuance of a letter of
request to Grunenthal GmbH and that the Court is also scheduled to hear oral argument on Par’s
motion to compel (D.I. 152) on July 11, Par requests that the oral argument proceed as currently
scheduled. Oral argument will allow counsel to fully explain Grunenthal’s role in the
development of extended release tramadol, and the significance of such information to the issues
in this case. Moreover, the Court will be fully apprised of the status of the case as we head
toward a November, 2008 trial.
Respectfully,
/s/ Frederick L. Cottrell, III
Frederick L. Cottrell, III (#2555)
FLC/lll
cc: James S. Green, Esquire (By CM/ECF)
Jack B. Blumenfeld, Esquire (By CM/ECP)
Richard D. Kirk, Esquire (By CM/ECF)
Mary W. Bourke, Esquire (By CM/ECF)
Robert J. Goldman, Esquire (By Electronic Mail)
Richard A. Inz, Esquire (By Electronic Mail)
ru.r1-2297293-1 I I I
One Rodney Square I 920 North King Street I Wilmington, DE 19801 I Phone: 302.-651-7700 I Fax: 302-651-7701
www.rlf.com